[Elsevier] Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial

 Close Closed
Marilena Post time 2024-5-9 18:03:04 | Show all posts |Read mode
Reward10points

journal£ºMolecular Therapy

Authors£ºJeong Heo; Ja-Der Liang; Chang Won Kim; Hyun Young Woo; I-Lun Shih; Tung-Hung Su; Zhong-Zhe Lin; So Young Yoo; Stanley Chang; Yasuo Urata; Pei-Jer Chen

Published date£º2023-7-

DOI£º10.1016/j.ymthe.2023.04.006

PDF link£ºhttps://www.sciencedirect.com/sc ... 525001623002046/pdf

Article link£ºhttp://dx.doi.org/10.1016/j.ymthe.2023.04.006

Article Source£ºElsevier BV¡£


Remark£º
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    0

Latest Reply

Return to the list